Jiangsu Historical Income Statement
688399 Stock | 70.20 0.17 0.24% |
Historical analysis of Jiangsu Bioperfectus income statement accounts such as Interest Expense of 7.3 M, Selling General Administrative of 275.6 M or Total Revenue of 383 M can show how well Jiangsu Bioperfectus Technologies performed in making a profits. Evaluating Jiangsu Bioperfectus income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Jiangsu Bioperfectus's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Jiangsu Bioperfectus latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jiangsu Bioperfectus is a good buy for the upcoming year.
Jiangsu |
About Jiangsu Income Statement Analysis
Jiangsu Bioperfectus Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Jiangsu Bioperfectus shareholders. The income statement also shows Jiangsu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Jiangsu Bioperfectus Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Jiangsu Bioperfectus generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Jiangsu Bioperfectus Technologies minus its cost of goods sold. It is profit before Jiangsu Bioperfectus operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Jiangsu Bioperfectus' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Jiangsu Bioperfectus current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Jiangsu Bioperfectus' Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 7.3 M, whereas Tax Provision is projected to grow to (1.8 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 2.0B | 3.4B | 257.7M | 244.8M | Total Revenue | 2.8B | 5.5B | 403.2M | 383.0M |
Jiangsu Bioperfectus income statement Correlations
Click cells to compare fundamentals
Jiangsu Bioperfectus Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Not Found
Jiangsu Bioperfectus income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Tax Provision | 10.9M | 141.4M | 198.6M | 310.8M | (1.9M) | (1.8M) | |
Net Interest Income | 3.9M | 7.5M | 22.6M | 33.4M | 48.9M | 51.3M | |
Interest Expense | 3.9M | 83.1K | 4.0M | 5.3M | 6.9M | 7.3M | |
Selling General Administrative | 96.6M | 340.9M | 462.8M | 547.3M | 291.8M | 275.6M | |
Total Revenue | 288.8M | 1.7B | 2.8B | 5.5B | 403.2M | 383.0M | |
Gross Profit | 236.1M | 1.3B | 2.0B | 3.4B | 257.7M | 244.8M | |
Operating Income | 91.0M | 939.1M | 1.4B | 2.5B | (214.5M) | (203.8M) | |
Net Income From Continuing Ops | 83.8M | 819.6M | 1.2B | 1.8B | (373.8M) | (355.1M) | |
Ebit | 83.4M | 911.0M | 1.3B | 2.5B | 2.8B | 3.0B | |
Research Development | 38.6M | 72.1M | 106.6M | 185.8M | 135.5M | 82.6M | |
Cost Of Revenue | 52.7M | 389.9M | 876.3M | 2.2B | 145.5M | 138.2M | |
Total Operating Expenses | 197.8M | 800.5M | 1.5B | 3.1B | 617.7M | 907.9M | |
Income Before Tax | 94.7M | 961.0M | 1.4B | 2.1B | (375.7M) | (356.9M) | |
Net Income | 83.8M | 819.6M | 1.2B | 1.8B | (373.8M) | (355.1M) | |
Interest Income | 4.0M | 7.8M | 26.8M | 39.2M | 56.0M | 58.8M | |
Other Operating Expenses | 1.5M | 5.0M | 5.3M | 11.0M | 12.6M | 13.3M | |
Ebitda | 108.1M | 983.2M | 1.4B | 2.2B | 2.6B | 2.7B | |
Reconciled Depreciation | 17.4M | 22.1M | 41.3M | 94.0M | 78.9M | 43.6M | |
Net Income Applicable To Common Shares | 83.8M | 819.6M | 1.2B | 1.8B | 2.1B | 2.2B | |
Income Tax Expense | 10.9M | 141.4M | 198.6M | 310.8M | 357.4M | 375.3M |
Currently Active Assets on Macroaxis
Other Information on Investing in Jiangsu Stock
Jiangsu Bioperfectus Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Jiangsu Bioperfectus shareholders. The income statement also shows Jiangsu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).